Kuhn, N. F., Lopez, A. V., Li, X., Cai, W., Daniyan, A. F., & Brentjens, R. J. (2020). CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function. Nature Portfolio.
Chicago Style (17th ed.) CitationKuhn, Nicholas F., Andrea V. Lopez, Xinghuo Li, Winson Cai, Anthony F. Daniyan, and Renier J. Brentjens. CD103+ CDC1 and Endogenous CD8+ T Cells Are Necessary for Improved CD40L-overexpressing CAR T Cell Antitumor Function. Nature Portfolio, 2020.
MLA (8th ed.) CitationKuhn, Nicholas F., et al. CD103+ CDC1 and Endogenous CD8+ T Cells Are Necessary for Improved CD40L-overexpressing CAR T Cell Antitumor Function. Nature Portfolio, 2020.
Warning: These citations may not always be 100% accurate.